Synopsis World Market Intelligence's "Nordic Mining ASA (NOM) - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, financial ratios, key competitors, financial analysis, recent developments, key employees as well as company locations and subsidiaries.
Summary This report is a crucial resource for industry executives and anyone looking to access key information about "Nordic Mining ASA"
The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market Intelligence strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope - Identifies crucial company information about "Nordic Mining ASA" along with major products and services for business intelligence requirements.
- Provides key ratios on company's financial performance.
- Identifies key employees to assist with key business decisions.
- Provides annual and interim financial ratios.
Reasons To Buy - Enhance your understanding of "Nordic Mining ASA"
- Increase business/sales activities by understanding customers’ businesses better.
- Recognize potential partnerships and suppliers.
- Qualify prospective partners, affiliates or suppliers.
- Acquire up-to-date company information and an understanding of the company’s financial health.
Key Highlights Nordic Mining ASA (Nordic Mining) is a mineral exploration company. The company carries out exploration, extraction, production, and processing of industrial minerals and metals in Norway. Its mineral resources include energy minerals, metallic minerals, industrial minerals, and construction minerals. Nordic Mining's products include anorthosite which is produced by its subsidiary, Gudvangen Stein AS; Titanium feedstock which is produced by Nordic Rutile from the mineral deposit at Engebofjellet; and quartz which is produced from the quartz deposit in Kvinnherad. The company also plans to start mining of lithium bearing spodumene and production of lithium carbonate through its subsidiary Keliber Oy in Finland. It operates in Norway, Germany, Poland, Sweden, Denmark, Lithuania, Malta, and the Netherlands. Nordic Mining is headquartered in Oslo, Norway.
Our reports have been used by over 10K customers, including:
Summary PLx Pharma Inc (PLx Pharma) is a pharmaceutical company that develops patent-protected delivery systems.The company offers products such as PLxGuard delivery system, PLxGuard pipeline products, and PL1100 and PL1200 ibuprofen products. Its PLxGuard delivery system are used in enhancement of efficacy of drugs,...
Summary BerGenBio ASA (BerGenBio) is a clinical-stage biopharmaceutical company that develops drugs to treat multiple aggressive cancers.The company develops epithelial-mesenchymal transition inhibitors for acquired cancer drug-resistance and metastasis. Its BGB324 is an AXL kinase inhibitor which finds application...
Summary Nordic Nanovector ASA (Nordic Nanovector), formerly Nordic Nanovector AS is a developer and commercializer of antibody radionuclide conjugates for the treatment of haematological cancers.The company’s lead product candidate includes Betalutin, an antibody radionuclide conjugate developed for the treatment of non-Hodgkin...
Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations.The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The...
Summary Serodus ASA (Serodus) is a drug development company that develops treatments for unmet clinical needs in the areas of diabetes and diabetic comorbidities.The company’s pipeline products include SER150DN, an anti-inflammatory compound under development for diabetic nephropathy; SER130AMI, an interleukin-4 agonist...
Summary Targovax ASA (Targovax) is a developer and commercializer of immunotherapies for the treatment of cancer patients.The company’s lead candidates include TG0, a peptide-based therapeutic anti-cancer vaccine under development for pancreatic cancer; and ONCOS-102 is an adenovirus-based pipeline product for solid tumor...